Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Serum soluble CD163 levels in patients with influenza-associated encephalopathy.

Hasegawa S, Matsushige T, Inoue H, Takahara M, Kajimoto M, Momonaka H, Ishida C, Tanaka S, Morishima T, Ichiyama T.

Brain Dev. 2013 Aug;35(7):626-9. doi: 10.1016/j.braindev.2012.10.005. Epub 2012 Nov 11.

PMID:
23149357
2.

Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.

Davis BH, Zarev PV.

Cytometry B Clin Cytom. 2005 Jan;63(1):16-22.

3.

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.

Eur J Haematol. 2014 Jul;93(1):41-7. doi: 10.1111/ejh.12296. Epub 2014 Mar 20.

PMID:
24612259
4.

Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.

Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.

Scand J Immunol. 2014 Dec;80(6):417-23. doi: 10.1111/sji.12222.

PMID:
25346048
5.

Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.

Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC.

J Infect Dis. 2011 Jul 1;204(1):154-63. doi: 10.1093/infdis/jir214.

6.

Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.

Kondelkova K, Krejsek J, Borska L, Fiala Z, Hamakova K, Andrys C.

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):158-62. doi: 10.1016/j.aller.2012.02.006. Epub 2012 Jul 4.

PMID:
22765877
7.

Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury.

Craig DG, Lee P, Pryde EA, Hayes PC, Simpson KJ.

Aliment Pharmacol Ther. 2013 Dec;38(11-12):1395-404. doi: 10.1111/apt.12530. Epub 2013 Oct 20.

8.

Soluble CD163.

Møller HJ.

Scand J Clin Lab Invest. 2012 Feb;72(1):1-13. doi: 10.3109/00365513.2011.626868. Epub 2011 Nov 7. Review.

PMID:
22060747
9.

Levels of soluble CD163 and severity of malaria in children in Ghana.

Kusi KA, Gyan BA, Goka BQ, Dodoo D, Obeng-Adjei G, Troye-Blomberg M, Akanmori BD, Adjimani JP.

Clin Vaccine Immunol. 2008 Sep;15(9):1456-60. doi: 10.1128/CVI.00506-07. Epub 2008 Jul 16.

10.

Soluble CD163: a marker molecule for monocyte/macrophage activity in disease.

Møller HJ, Aerts H, Grønbaek H, Peterslund NA, Hyltoft Petersen P, Hornung N, Rejnmark L, Jabbarpour E, Moestrup SK.

Scand J Clin Lab Invest Suppl. 2002;237:29-33.

PMID:
12570164
11.

Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.

Sugaya M, Miyagaki T, Ohmatsu H, Suga H, Kai H, Kamata M, Fujita H, Asano Y, Tada Y, Kadono T, Okochi H, Sato S.

J Dermatol Sci. 2012 Oct;68(1):45-51. doi: 10.1016/j.jdermsci.2012.07.007. Epub 2012 Jul 27.

PMID:
22884782
12.

Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.

Zanni MV, Burdo TH, Makimura H, Williams KC, Grinspoon SK.

Clin Endocrinol (Oxf). 2012 Sep;77(3):385-90. doi: 10.1111/j.1365-2265.2011.04284.x.

13.

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.

Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.

Arthritis Rheum. 2007 Mar;56(3):965-71.

14.

Soluble CD163, a product of monocyte/macrophage activation, is inversely associated with haemoglobin levels in placental malaria.

Chua CL, Brown GV, Hamilton JA, Molyneux ME, Rogerson SJ, Boeuf P.

PLoS One. 2013 May 22;8(5):e64127. doi: 10.1371/journal.pone.0064127. Print 2013.

15.

Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.

Kjærgaard AG, Rødgaard-Hansen S, Dige A, Krog J, Møller HJ, Tønnesen E.

PLoS One. 2014 Mar 17;9(3):e92331. doi: 10.1371/journal.pone.0092331. eCollection 2014.

16.

Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.

Schaer DJ, Schleiffenbaum B, Kurrer M, Imhof A, Bächli E, Fehr J, Moller HJ, Moestrup SK, Schaffner A.

Eur J Haematol. 2005 Jan;74(1):6-10.

PMID:
15613100
17.

Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.

Møller HJ, Nielsen MJ, Maniecki MB, Madsen M, Moestrup SK.

Immunobiology. 2010 May;215(5):406-12. doi: 10.1016/j.imbio.2009.05.003. Epub 2009 Jul 5.

PMID:
19581020
18.

Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.

Møller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, Attermann J, Nexø E, Kronborg G.

Crit Care Med. 2006 Oct;34(10):2561-6.

PMID:
16915112
19.
20.

Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.

Baeten D, Møller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F.

Arthritis Rheum. 2004 May;50(5):1611-23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk